According to the anti-cancer drug target information of GDSC, there are only one druggable gene (KIT) in the BrC24 and the connectivity loss scores of KIT was significantly larger in the individualized gene networks of the samples belonged to the second cluster (P-value = 1.24E-45, Figure 4C). Here, KIT is linked to cancer.